Discovery of TRV130, a G protein biased agonist of the μ-opioid receptor, for the treatment of acute severe pain

被引：0
|
作者：
Crombie, Aimee [1 ]
Chen, Xiao-Tao [1 ]
Pitis, Philip [1 ]
Liu, Guodong [1 ]
Yuan, Catherine [1 ]
Gotchev, Dimitar [4 ]
Yamashita, Dennis [3 ]
Violin, Jonathan [2 ]
机构：
[1] Trevena Inc, Chem, King Of Prussia, PA USA
[2] Trevena Inc, Biol, King Of Prussia, PA USA
[3] GSK, Discovery Partnerships Acad, Boston, PA USA
[4] Teva Pharmaceut, Chem, W Chester, PA USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2015年 / 249卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
34
引用
收藏
页数：2
相关论文
共 50 条
  • [31] OLICERIDINE (TRV130), A NOVEL μ RECEPTOR G PROTEIN PATHWAY SELECTIVE (μ-GPS) MODULATOR, HAS A DIFFERENTIATED PROFILE OF G PROTEIN AND β-ARRESTIN SIGNALING VERSUS OPIOIDS
    Gowen-MacDonald, W.
    Graczyk, T.
    Lark, M.
    Cowan, C.
    Gan, T. J.
    ANESTHESIA AND ANALGESIA, 2016, 122
  • [32] Discovery and Structural Explorations of G-Protein Biased μ-Opioid Receptor Agonists
    Li, Xiang
    Guo, Yanhao
    Li, Jing
    Yu, Zixing
    Cheng, Jingchao
    Ren, Fengxia
    Jia, Hongxin
    Zhang, Yatong
    Cui, Shiqiang
    Zhang, Tao
    Shi, Weiguo
    CHEMMEDCHEM, 2022, 17 (24)
  • [33] A G-protein-biased delta opioid receptor (DOPr) agonist with improved therapeutic profile for use in in chronic pain
    Conibear, A. E.
    Asghar, J.
    Helyes, S.
    Borbely, E.
    Kendall, D.
    von Mentzer, B.
    Kelly, E.
    BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (16) : 3048 - 3049
  • [34] TRV130 partial agonism and capacity to induce anti-nociceptive tolerance revealed through reducing available μ-opioid receptor number
    Singleton, Samuel
    Baptista-Hon, Daniel T.
    Edelsten, Emily
    McCaughey, Kirsty S.
    Camplisson, Ewan
    Hales, Tim G.
    BRITISH JOURNAL OF PHARMACOLOGY, 2021, 178 (08) : 1855 - 1868
  • [35] APOLLO-1: randomized, placebo- and active-controlled phase 3 study investigating oliceridine (TRV130), a novel μ receptor G protein Pathway Selective (μ-GPS) modulator, for management of moderate to severe acute pain following bunionectomy
    Skobieranda, F.
    Singla, N.
    Burt, D.
    Soergel, D.
    JOURNAL OF PAIN, 2017, 18 (04): : S31 - S32
  • [36] Binding Pathways of a G-Protein Biased μ-opioid Receptor agonist under Clinical Evaluation
    Schneider, Sebastian
    Provasi, Davide
    Filizola, Marta
    BIOPHYSICAL JOURNAL, 2016, 110 (03) : 591A - 591A
  • [37] APOLLO-1: RANDOMIZED, PLACEBO AND ACTIVE-CONTROLLED PHASE 3 STUDY INVESTIGATING OLICERIDINE (TRV130), A NOVEL μ RECEPTOR G PROTEIN PATHWAY SELECTIVE (μ-GPS) MODULATOR, FOR MANAGEMENT OF MODERATE TO SEVERE ACUTE PAIN FOLLOWING BUNIONECTOMY.
    Senagore, A.
    Soergel, D.
    DISEASES OF THE COLON & RECTUM, 2017, 60 (06) : E393 - E393
  • [38] Oliceridine, a G protein-selective ligand at the μ-opioid receptor, for the management of moderate to severe acute pain
    Gan, T. J.
    Wase, L.
    DRUGS OF TODAY, 2020, 56 (04) : 269 - 286
  • [39] A novel G protein-biased agonist at the μ opioid receptor induces substantial receptor desensitisation through G protein-coupled receptor kinase
    Groom, Sam
    Blum, Nina K.
    Conibear, Alexandra E.
    Disney, Alexander
    Hill, Rob
    Husbands, Stephen M.
    Li, Yangmei
    Toll, Lawrence
    Kliewer, Andrea
    Schulz, Stefan
    Henderson, Graeme
    Kelly, Eamonn
    Bailey, Chris P.
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 (07) : 943 - 957
  • [40] RAPID ONSET OF PAIN RELIEF WITH OLICERIDINE (TRV130), A NOVEL μ RECEPTOR G PROTEIN PATHWAY SELECTIVE (μ-GPS) MODULATOR, VS. MORPHINE: A PHASE 2A/B STUDY ANALYSIS
    Viscusi, E.
    Webster, L.
    Soergel, D.
    Burt, D. A.
    Skobieranda, F.
    Gan, T. J.
    ANESTHESIA AND ANALGESIA, 2016, 122
12345